Proiecte

The Europe’s Beating Cancer Plan has called for a new EU-Supported Cancer Screening Scheme to assure high performance of cancer screening programs across all the Member States (MS). The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancer as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers.

EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU. Seven specific objectives have been set for EUCanScreen:

1. Ensuring full implementation of evidence-based, cost-effective and quality-assured screening programmes for breast, cervical and colorectal cancers;
2. Preparing for implementation of evidence-based, cost-effective and quality-assured screening programmes for lung, prostate and gastric cancers;
3. Ensuring proper program governance and sustainability;
4. Ensuring better-quality, timelier and comparable data collection and monitoring of screening programmes;
5. Ensuring equal access of eligible EU citizens to screening programmes and reducing cancer inequalities;
6. Ensuring capacity building in cancer screening, and
7. Ensuring collaboration and coherence with related projects funded under EU Programmes.

The work-plan of EUCanScreen has been built on the results of previous and ongoing major EU activities in screening; it is designed within eleven closely interlinked work-packages. The consortium is bringing together well-performing screening programs to those that require substantial improvements. Altogether 29 partnering countries are represented in the consortium, including 25 EU MS, Ukraine, Moldova, Norway and Iceland. The project will be coordinated by the University of Latvia, and will involve additional 28 competent authorities, 61 affiliated partners, and 7 associated partners.

IOCN plays a pivotal role in EUCanScreen, leading Work Package 11 (WP11) on Capacity building, IOCN having substantial involvement in similar activities within other European projects. The overall objective is to empower current and future leaders of cancer screening in exemplary countries to successfully implement or improve organised population-based screening in their respective countries. Beside coordination of all seven Tasks involved in WP11, technical and scientific support, establishing a communication plan to keep team members updated on progression, monitoring progress throughout the advancement of the Joint Action, IOCN will host one 3-day hybrid specialist training course focusing on AIS, pregnancy and immunosuppressed women, in the frame of Task 11.5 “Cervical cancer screening specialist training and regional training centre” led by Norway Public Health Institute.

Official website: https://www.dypede.gr/eucanscreen/